Gottlieb, Andrea http://orcid.org/0000-0003-1189-3644
Flor, Inga
Nimzyk, Rolf
Burchardt, Lars
Helmke, Burkhard
Langenbuch, Marc
Spiekermann, Meike
Feidicker, Susanne
Bullerdiek, Jörn http://orcid.org/0000-0003-0406-379X
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 19 July 2020
Accepted: 24 August 2020
First Online: 9 October 2020
Compliance with ethical standards
: All samples of induced and spontaneous abortions investigated were initially taken for diagnostic purposes. Samples were de-identified before their use following the rules of the Helsinki declaration. All full-term placentas and serum samples were collected after a written informed consent was given by the mother. The study was approved by the local ethics committee (Ärztekammer Bremen, reference number 330).
: The authors declare competing financial interests because J.B. is an applicant and I.F. and J.B. are named inventors of a patent application (WO2013079701 A2) claiming the use of C19MC miRNAs for immunomodulation.